Smith Alan E

Avg. Two Year Performance

No purchase track record
(10%) Avg. Sale Return
(5%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)4%< 1%(6%)(10%)
Sale Success Rate5 of 177 of 175 of 174 of 173 of 17
Drugs » Biotechnology

Sr VP,Chief Scientific Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--